3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
3
Neoplasms
2
Plasmacytoma
1
Pathologic Complete Response
1
Multiple Myeloma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Large Granular Lymphocytic
1
Hepatic Insufficiency
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
7
Gemcitabine
6
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
toripalimab
2
Bevacizumab
2
tocilizumab
1
tislelizumab
1
spartalizumab
1
penpulimab
1
atezolizumab
1
Vitamin D
1
Tablets
1
Surveys and Questionnaires
1
Phantoms, Imaging
1
Oral Hygiene
1
Observation
1
Magnetic Resonance Spectroscopy
1
Immunotherapy
1
Immunohistochemistry
1
Immunoglobulin G
1
Fluorouracil
1
Disulfides
1
Dexamethasone
1
Chemoradiotherapy
1
Cetuximab
1
Carboplatin
1
Capecitabine
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Neoplasms
×
cc-486
×
1 year
×
Clear all
No trials found.